While we do not exclude the possibility that host cytokines such as IL-4 synergize with FABP5 signaling, our data highlight the sufficiency of tumor-derived FABP5 to remodel the immune microenvironment, even in the presence of competing endogenous signals. Here, FABP5 is linked to neoplasm.